0001628280-20-014963.txt : 20201028 0001628280-20-014963.hdr.sgml : 20201028 20201028145337 ACCESSION NUMBER: 0001628280-20-014963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201016 FILED AS OF DATE: 20201028 DATE AS OF CHANGE: 20201028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIDRANSKY DAVID CENTRAL INDEX KEY: 0001277161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11504 FILM NUMBER: 201268265 MAIL ADDRESS: STREET 1: JOHNS HOPKINS UNIVERSITY STREET 2: 720 RUTLAND AVENUE CITY: BALTIMORE STATE: MD ZIP: 21205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC. CENTRAL INDEX KEY: 0000771856 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521401755 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 410-369-0365 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC. DATE OF NAME CHANGE: 20070220 FORMER COMPANY: FORMER CONFORMED NAME: CHAMPIONS SPORTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL GROUP INC DATE OF NAME CHANGE: 19860319 4 1 wf-form4_160391120277763.xml FORM 4 X0306 4 2020-10-16 0 0000771856 CHAMPIONS ONCOLOGY, INC. CSBR 0001277161 SIDRANSKY DAVID C/O CHAMPIONS ONCOLOGY, INC. ONE UNIVERSITY PLAZA, SUITE 307 HACKENSACK NJ 07601 1 0 0 0 Common Stock 2020-10-16 4 M 0 16667 5.46 A 758334 D Common Stock 2020-10-16 4 F 0 10100 9.01 D 748234 D Option to purchase Common Stock 5.46 2020-10-16 4 M 0 16667 0 D 2020-11-02 Common Stock 16667.0 0 D Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 16, 2020. The options vest and are exercisable over a twelve month period, with vesting to occur on November 2, 2015, February 2, 2016, May 2, 2016 and August 2, 2016, respectively. /s/ David Sidransky 2020-10-28